T1	Participants 20 77	persons with cystic fibrosis and the G551D-CFTR mutation.
T2	Participants 395 460	39 adults with cystic fibrosis and at least one G551D-CFTR allele
T3	Participants 1912 1934	treat cystic fibrosis.
